Zhao W, Zhao Y, Chen L, Sun Y, Fan S
Open Med (Wars). 2022; 17(1):151-159.
PMID: 35071776
PMC: 8749127.
DOI: 10.1515/med-2021-0348.
Peng F, Fan H, Li S, Peng C, Pan X
Int J Mol Sci. 2021; 22(14).
PMID: 34299149
PMC: 8305963.
DOI: 10.3390/ijms22147526.
Lee L, Papadopoli D, Jewer M, Del Rincon S, Topisirovic I, Lawrence M
Trends Cancer. 2020; 7(2):134-145.
PMID: 33067172
PMC: 8023421.
DOI: 10.1016/j.trecan.2020.09.005.
Torres R, Lang U, Hejna M, Shelton S, Joseph N, Shain A
J Invest Dermatol. 2019; 140(1):164-173.e7.
PMID: 31580842
PMC: 6926155.
DOI: 10.1016/j.jid.2019.06.126.
Zhu Q, Zhou Q, Dong L, Huang Z, Wu F, Deng X
Technol Cancer Res Treat. 2018; 17:1533034618775509.
PMID: 29807462
PMC: 5974564.
DOI: 10.1177/1533034618775509.
Microarray analysis of miRNA expression profiles following whole body irradiation in a mouse model.
Aryankalayil M, Chopra S, Makinde A, Eke I, Levin J, Shankavaram U
Biomarkers. 2018; 23(7):689-703.
PMID: 29799276
PMC: 6982201.
DOI: 10.1080/1354750X.2018.1479771.
Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R
J Exp Clin Cancer Res. 2017; 36(1):161.
PMID: 29145896
PMC: 5689139.
DOI: 10.1186/s13046-017-0622-1.
Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
Kuznetsov V, Tang Z, Ivshina A
BMC Genomics. 2017; 18(Suppl 6):692.
PMID: 28984201
PMC: 5629558.
DOI: 10.1186/s12864-017-4027-5.
The crosstalk between lncRNA and microRNA in cancer metastasis: orchestrating the epithelial-mesenchymal plasticity.
Cao M, Jiang Y, Tang Y, Liang X
Oncotarget. 2016; 8(7):12472-12483.
PMID: 27992370
PMC: 5355358.
DOI: 10.18632/oncotarget.13957.
Regulation of epithelial-mesenchymal transition through microRNAs: clinical and biological significance of microRNAs in breast cancer.
Peng F, Xiong L, Tang H, Peng C, Chen J
Tumour Biol. 2016; 37(11):14463-14477.
PMID: 27644253
DOI: 10.1007/s13277-016-5334-1.
Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer.
Yu Y, Zhao Y, Sun X, Ge J, Zhang B, Wang X
Oncotarget. 2015; 6(33):34423-36.
PMID: 26460733
PMC: 4741463.
DOI: 10.18632/oncotarget.5406.
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer.
Duhachek-Muggy S, Zolkiewska A
BMC Cancer. 2015; 15:93.
PMID: 25886595
PMC: 4352249.
DOI: 10.1186/s12885-015-1108-1.
Posttranscriptional deregulation of signaling pathways in meningioma subtypes by differential expression of miRNAs.
Ludwig N, Kim Y, Mueller S, Backes C, Werner T, Galata V
Neuro Oncol. 2015; 17(9):1250-60.
PMID: 25681310
PMC: 4588755.
DOI: 10.1093/neuonc/nov014.
Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization.
Meseure D, Alsibai K, Nicolas A
Cancer Microenviron. 2014; 7(3):95-115.
PMID: 25523234
PMC: 4275542.
DOI: 10.1007/s12307-014-0158-2.
Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L, Macho-Maschler S, Custic I, Niemiec J, Guio-Carrion A, Hasenfuss S
Cell Death Differ. 2014; 22(2):336-50.
PMID: 25301070
PMC: 4291495.
DOI: 10.1038/cdd.2014.157.
OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.
Lu Y, Chang J, Liao C, Kang C, Huang S, Chen I
Mol Cancer. 2014; 13:218.
PMID: 25233933
PMC: 4176851.
DOI: 10.1186/1476-4598-13-218.
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs.
Uppal A, Ferguson M, Posner M, Hellman S, Khodarev N, Weichselbaum R
Clin Exp Metastasis. 2014; 31(6):735-48.
PMID: 24968866
PMC: 4138440.
DOI: 10.1007/s10585-014-9664-3.
MicroRNA-200b targets protein kinase Cα and suppresses triple-negative breast cancer metastasis.
Humphries B, Wang Z, Oom A, Fisher T, Tan D, Cui Y
Carcinogenesis. 2014; 35(10):2254-63.
PMID: 24925028
PMC: 4178468.
DOI: 10.1093/carcin/bgu133.
miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J, Xie F, Bao X, Chen W, Xu Q
Mol Cancer. 2014; 13:121.
PMID: 24885626
PMC: 4040483.
DOI: 10.1186/1476-4598-13-121.
MicroRNAs: master regulators of drug resistance, stemness, and metastasis.
Raza U, Zhang J, Sahin O
J Mol Med (Berl). 2014; 92(4):321-36.
PMID: 24509937
DOI: 10.1007/s00109-014-1129-2.
